U.S., May 21 -- An application to own the trademark for 'MTAC' has been filed on Feb. 27, 2023.
Owner(s):
Avilar Therapeutics, Inc.; 400 Totten Pond Road, Suite 110, , Massachusetts
Goods and/or Services:
For: Research and development in the field of pharmaceutical preparations that bind to mannose 6-phosphate (M6P) receptors
Class(es): 100, 101
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-05-20&serialNumber=97813153
Disclaimer: Curated by HT Syndication....